A 32-year-old woman with an ectopic adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma (EAPA) is presented. She had rapidly gained weight and suffered recurrent facial acne for a few years but lacked the typical Cushingoid features. Endocrine examinations revealed that her plasma ACTH was markedly high (196 to 280 pg/ml) without showing normal circadian rhythm and failed to respond to corticotropin-releasing hormone stimulation. Her cortisol levels ranged from 22 to 30 mg/dl throughout observation but low doses (1 and 2 mg) of dexamethasone failed to suppress either ACTH or cortisol level. Magnetic resonance imaging study revealed a 3-cm mass occupying the sphenoidal sinus with partial enhancement by gadolinium, which was separated from the normal pituitary in the sella region. The tumor resected by transsphenoidal surgery was histologically diagnosed as an ACTH-producing pituitary adenoma. After surgery her weight gain and acne remitted in accordance with decreases in plasma ACTH. Analysis of patient plasma by gel filtration method revealed the existence of big ACTH molecules eluted with a peak of authentic 1-39 ACTH, suggesting that this biologically less-active ACTH might be the reason why overt features of Cushing's syndrome failed to develop in this case. Although EAPA is clinically rare in parasellar disorders, the presence of ectopic pituitary adenoma should be considered in such cases showing ACTH hypersecretion without typical Cushingoid features.
RECENT development of pituitary imaging has enabled to clarify detailed localization of pituitary tumors. Indeed many ectopic pituitary adenomas have been detected around the sella region including sphenoid sinus, suprasellar region, clivus, and cavernous sinus [1] . Among the ectopic pituitary adenomas, Cushing's syndrome caused by ectopic adrenocortico-tropin (ACTH)-secreting pituitary adenoma (EAPA) has been reported in 30 cases . In the EAPA cases, ACTH is overproduced in the histologicallyconfirmed pituitary adenoma apart from normal pituitary gland. In particular cases in which EAPA borders the pituitary gland or is located in cavernous sinus, it is quite difficult to differentiate EAPA from common Cushing's disease or other ectopic ACTH syndromes caused by various neoplasms, since the precise clinical and/or endocrine features have not been characterized in EAPA. Ectopic pituitary adenomas per se are an uncommon condition and comprised predominantly of EAPA, most of which shows overt features of Cushing's syndrome [1] . We present here a case of EAPA showing mild clinical features of Cushing's syndrome. This is the first case to demonstrate the presence of big ACTH molecules in the plasma of an EAPA case.
Case Report
A 32-year-old Japanese woman who had complained of chronic headache was referred to our hospital for consulting regarding a brain tumor occupying the sphenoid sinus that was incidentally discovered by a screening examination using cranial magnetic resonance imaging (MRI). Her past medical history was negative except for ureterolithiasis and her family history was not particularly remarkable. She had gained her body weight ~5 kg for the last few months and when admitted she weighed 60.3 kg and was 163.0 cm tall (body mass index, 22.7 kg/m 2 ). The blood pressure was 110/58 mmHg and pulse rate was regularly 84 bpm. The acne spreading on face and anterior chest were remarkable but the typical features of Cushing's syndrome including moon face, central/truncal obesity, buffalo hump, striae cuitis and pigmentation and atrophy of the skin, muscle weakness, and hirsuitism were not apparent. Laboratory examinations revealed some abnormalities including neutrophilia (14,700/ml with 11% lymphocytes and 0% eosinophils) and hypokalemia (serum potassium, 3.1 to 3.6 mmol/l). Liver and renal functions and glucose tolerance were found to be normal. Cranial MRI revealed a mass lesion (~3 cm in diameter) occupying the sphenoid sinus without suprasellar extension. The sphenoid mass was shown to be low on T1-images and partially enhanced by gadolinium. Normal pituitary was clearly detected and separated from the intra-sphenoid mass by a dural septum ( Fig. 1A and B ). On her endocrine examinations, plasma ACTH level was markedly increased (196 to 280 pg/ml; normal, 9-52) but the serum cortisol level was not remarkable (23 to 27 mg/dl; normal [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Daily secretion of ACTH and cortisol lacked the normal circadian rhythm ( Fig. 2A ). Dexamethasone administration of (1 and 2 mg) failed to suppress either serum ACTH or F levels ( Fig. 2B ). CRH stimulation (100 mg iv.) did not significantly increase either ACTH or cortisol level ( Fig. 3A ). Other pituitary hormones, such as GH, LH, FSH, PRL and TSH, were within the normal range. The responses of other pituitary hormones to GRH, GnRH and TRH were also found to be normal. Upon confirming the diagnosis with Cushing's syndrome caused by EAPA, a transsphenoidal surgery was performed; however, only up to 60% of the EAPA mass was removed. The resected tumor was pathologically diagnosed as pituitary adenoma ( Fig. 4A ) and proven to be ACTH-positive in the cytoplasm ( Fig. 4B ). After surgery the basal levels of ACTH (77.7 to 87.1 pg/ml) and cortisol (5.5 to 11.9 mg/dl) and urinary secretion of steroid metabolites were markedly decreased but ACTH levels still remained moderately high. Although the daily profile of ACTH and cortisol was not completely normalized ( Fig. 2A) , dexamethasone caused the sufficient suppression of basal levels of ACTH and cortisol (Fig.  2B ). The response of ACTH and cortisol to exogenous CRH became almost normal after the sphenoidal surgery ( Fig. 3B ). and coronal scan (B). Note that enhanced normal pituitary is separated from the partially enhanced mass lesion in the sphenoid sinus.
Analysis of molecular size of plasma ACTH
Analysis of molecular size of circulating immunoreactive (IR)-ACTH was performed by gel chromatography using a method similar to the one we previously reported [24] . The patient plasma collected after surgery was used for the ACTH analysis. In brief, the plasma sample stored at -40ºC was extracted using SEP-PAK C 18 cartridge (Waters, Milford, MA). The recovery yield of ACTH was 85 to 90%. The plasma extract (3 ml volume) was acidified (pH 1.5) and applied to Sephadex G-75 column (1´70 cm, Amersham-Pharmacia Biotech) and eluted with 1% formic acid. Each 2 ml-fraction was fractionated and lyophilized. ACTH concentration of each fraction was determined by immunoradiometric assay (IRMA; ACTH IRMA Yuka, Mitsubishi Chemical, Tokyo) and radioimmunoassay (RIA) using an ACTH-specific antibody supplied by NIH. The detection limits for IRMA and RIA were 1 pg/ml and 2 pg/ml, respectively. IRMA showed a main IR-ACTH peak eluted at the position of 1-39 ACTH and two small peaks eluted earlier than 1-39 ACTH (Fig. 5A ). RIA also revealed main IR-ACTH at the position of 1-39 ACTH with small shoulder peaks and two peaks before the elution of the 1-39 ACTH (Fig. 5B ). These two peaks of high molecular weight IR-ACTH were more highly detected in RIA compared to IRMA.
Discussion
Most pituitary adenomas are pathologically benign but are sometimes found in the ectopic regions around the sella without any continuity to intrasellar normal pituitary tissue, which unexpectedly complicates its clinical diagnosis before surgery. As reviewed in Table 1 , 31 patients (22 females and 9 males [1-23]) with EAPA including our case have been reported since the first case was reported in 1975 by Ortiz-Suarez and Erickson [2] . The mean age of the patients with EAPA is 36 ± 3 years old (mean ± SEM; ranged 6 to 76 years old). In 10 patients with EAPA the tumor was located in the sphenoid sinus, 9 patients in the suprasellar region, and 4 or 5 patients in the carvenous sinus or other parasellar region. An extracranial lesion was also found in the ovarian teratoma [9] . In addition, 5 cases of EAPA cases were morphologically detected as empty sella. These clinical features in EAPA were similar to that seen in all ectopic pituitary adenomas. Interestingly, most (84%) of these EAPA cases showed overt features of Cushing's syndrome. Only 5 cases including our case have been found to be silent or to have subclinical features of Cushing's syndrome, although we cannot identify the endocrinological difference between overt and less Cushingoid features due to the lack of sufficient data reported (see Table 1 ). Cortisol secretions from 50% (8 out of 16 cases) of the EAPA examined were found to be responsible to high dose (8 mg) dexamethasone suppression while none of the 14 EAPA cases examined were responsive to low dose (1 to 2 mg) dexamethasone, which suggests a distinct feature of ACTH secretion by EAPA from ectopic ACTH syndrome due to neoplasm.
As for the origin of ectopic pituitary tumors including EAPA, several explanations have been proposed [21] . Pituitary cells could be deposited along the route of embryogenic development of the anterior pituitary, namely Rathke's pouch, and then the remnant tissue may develop into hormonally active adenomas in the ectopic regions such as sphenoid or cavernous sinus. As it develops, Rathke's pouch extends toward the third ventricle of diencephalons, and the remnants may be retained in the sphenoid sinus, sphenoid bone, or possibly within the sella turcica separated from the normal pituitary gland. The possibility of direct and local invasion of pituitary adenoma into the adjacent structures cannot be completely excluded [25, 26] . It is also postulated that deposits of pituitary cells in the subarachnoid space could be implanted during dissemination through cerebrospinal fluid as documented by Ogilvy and Jakubowski [27] . EAPA have been reported to occur in various parts of the cranial cavity. Radiologically and surgically, the direct tissue continuity between tumors and the intrasellar tissue should be evaluated to diagnose the EAPA. In the present case, no clear tissue connection was identified in our patient by MRI and even during surgery. However, careful follow-up study must be performed for early detection of recurrence from the remnant adenoma tissue. The main circulating ACTH molecules of this patient were found to be 1-39 ACTH but higher molecular weight ACTH detected by both IRMA and RIA was also present in the same plasma after the pituitary adenomectomy. Two peaks of high molecular weight ACTH clearly detected by RIA were smaller in IRMA, which might be ascribed to low cross-reactivity of antibodies employed in IRMA as compared to the high molecular weight ACTH although we could not accurately quantify the levels of cross-reaction by IRMA and RIA. Her plasma ACTH after surgery was most likely secreted from both of the remnant EAPA and the normal pituitary corticotropes although unfortunately we could not analyze the plasma samples before surgery. Given that giant corticotropinomas are occasionally found to be impaired in terms of proopiomelanocortin (POMC) processing [28, 29] , high molecular weight ACTH in this patient's plasma detected by RIA may have an impaired activity for processing the POMC precursor molecule. Regarding Cushing's disease due to corticotropinomas, the ratio of circulating ACTH (pg/ml by IRMA) to cortisol (mg/dl) was found to be 2.4 to 2.6 or 5.1 to 5.5 in cases of microadenoma or macroadenoma, respectively [30] . Based on this finding, the present case [7.25 to 12.1] and the other three [8.08, 12.0 and 8.0] out of 16 EAPA cases documented (see Table 1 ) were shown to have relatively high ratios of ACTH (pg/ml) to cortisol (mg/dl) com- pared to common Cushing's diseases, although these three cases, unlike our case, were reported to have completely overt Cushingoid features including moon face, truncal obesity, skin striae, pigmentation and atrophy, cervicodorsal hump, hypertension and diabetes mellitus [4, 13, 15] . Although the discrepancy of clinical symptoms and endocrine profile could be related to the individual sensitivity to cortisol, it is also possible that an aberrant less-active ACTH molecule exists in the plasma of these EAPA patients [31] . In the present case, the existence of big ACTH molecules may be associated with the less pronounced Cushingoid features. Further endocrine profiling of EAPA cases in comparison with all ectopic pituitary adenomas, common Cushing's disease and ectopic ACTH syndrome is needed to characterize an EAPA entity.
In summary, we have reported the case of a less Cushingoid female patient due to EAPA which secreted aberrant ACTH together with authentic ACTH. Careful examination by radiological and endocrinological aspects should be required for the diagnosis and follow-up after surgery.
